Mark R. Hake

Mark R. Hake

Mark R. Hake, CFA is a financial analyst and entrepreneur. He has been a Chartered Financial Analyst (CFA) for 31 years and has owned his own investment management and investment research firms that focused on value stocks, both in the U.S. and overseas.

Mark writes over 600 articles per year on stocks, cryptos, SPACs, convertibles, ETFs, and other financial securities. He has been ranked with 5 stars by TipRanks.com (under “Mark R. Hake”) with an average return of over 22% annually and #36 out of 8,116 writers. Presently he authors articles on Medium.com and other sites.

Mark also invests in public and private equities and has acted as a hedge fund manager and portfolio manager for various money management firms. He has also acted as CFO and Chief Strategy Officer for several fin-tech and software companies.

You can follow Mark on LinkedIn and on TipRanks.

Recent Articles

Dividend-Heavy Verizon Stock Is Shockingly Undervalued Right Now

Verizon Communications stock is worth at least 55% more given its history. VZ stock is undervalued based on a comparison with its peers, its history, and its average dividend yield.

Free Cash Flow Is a Possible Bright Spot for General Electric

General Electric expects a prolonged recovery. GE stock is likely to be 72% to 129% higher by 2021 if industrial FCF returns by then.

Royalty Pharma’s Cash Flow Growth Will Power the Stock Higher

Royalty Pharma's cash flow growth will power the stock higher. If cash flow continues at this pace, RPRX stock could rise by at least 88% over the next three years.

Buying iBio As a Vaccine Winner Is a Waste of Money

Don't waste money on iBio to bet on a Covid-19 vaccine winner. Since IBIO stock has risen so much, the probability of making money on this stock is extremely low.

A Reinstated 7% Dividend Makes MFA Financial Attractive

MFA Financial's reinstated dividend makes the stock's 7% yield attractive. MFA stock will likely double if the REIT has to hike its dividend.